Observational study: Adherence to Disease Modifying Anti Rheumatic Drugs in Tunisian patients with Juvenile Idiopathic Arthritis
Preprint in Research Square (August 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study
Article in Pediatric Rheumatology (November 2022)
Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database
Article in Therapeutics and Clinical Risk Management (August 2022)